News

All CGM Clinical Trials Depression Diabetes FDA funding investment jobs Mental Disorders mental health Modius Sleep Neurovalens Prediabetes Sleep Slim Stress Type 1 diabetes Type 2 diabetes Wearable technology Weight Loss
Neurovalens receives FDA clearance for medical device to treat insomnia

Neurovalens receives FDA clearance for medical device to treat insomnia

Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its Modius Sleep device.
October 31, 2023 — Craig McConnell